Publikation: Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the "European Human Biomonitoring Initiative" HBM4EU participating studies
dc.contributor.author | Fernández, Sandra | |
dc.contributor.author | Poteser, Michael | |
dc.contributor.author | Govarts, Eva | |
dc.contributor.author | Kolossa-Gehring, Marike | |
dc.contributor.author | Murawski, Aline | |
dc.contributor.author | Rüther, Maria | |
dc.contributor.author | Schmidt, Phillipp | |
dc.contributor.author | Vogel, Nina | |
dc.contributor.author | Weber, Till | |
dc.date.accessioned | 2024-06-16T12:34:14Z | |
dc.date.available | 2024-06-16T12:34:14Z | |
dc.date.issued | 2023 | |
dc.description.abstract | Little is known about exposure determinants of acrylamide (AA), a genotoxic food-processing contaminant, in Europe. We assessed determinants of AA exposure, measured by urinary mercapturic acids of AA (AAMA) and glycidamide (GAMA), its main metabolite, in 3157 children/adolescents and 1297 adults in the European Human Biomonitoring Initiative. Harmonized individual-level questionnaires data and quality assured measurements of AAMA and GAMA (urine collection: 2014-2021), the short-term validated biomarkers of AA exposure, were obtained from four studies (Italy, France, Germany, and Norway) in children/adolescents (age range: 3-18 years) and six studies (Portugal, Spain, France, Germany, Luxembourg, and Iceland) in adults (age range: 20-45 years). Multivariable-adjusted pooled quantile regressions were employed to assess median differences ((beta) coefficients) with 95% confidence intervals (95% CI) in AAMA and GAMA ((micro)g/g creatinine) in relation to exposure determinants. Southern European studies had higher AAMA than Northern studies. In children/adolescents, we observed significant lower AA associated with high socioeconomic status (AAMA: (beta) = -9.1 (micro)g/g creatinine, 95% CI -15.8, -2.4; GAMA: (beta) = -3.4 (micro)g/g creatinine, 95% CI-4.7, - 2.2), living in rural areas (AAMA: (beta) = - 4.7 (micro)g/g creatinine, 95% CI - 8.6, - 0.8; GAMA: (beta) = - 1.1 (micro)g/g creatinine, 95% CI -1.9, -0.4) and increasing age (AAMA: (beta)= -1.9 (micro)g/g creatinine, 95% CI -2.4, -1.4; GAMA: (beta) = -0.7 (micro)g/g creatinine, 95% CI -0.8, -0.6). In adults, higher AAMA was also associated with high consumption of fried potatoes whereas lower AAMA was associated with higher body-mass-index. Based on this large-scale study, several potential determinants of AA exposure were identified in children/adolescents and adults in European countries. © The Author(s) 2023 | en |
dc.format.extent | 1 Online-Resource (11 pages) | |
dc.format.medium | online resource | |
dc.identifier.doi | https://doi.org/10.60810/openumwelt-741 | |
dc.identifier.uri | https://openumwelt.de/handle/123456789/1302 | |
dc.language.iso | eng | |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | |
dc.title | Determinants of exposure to acrylamide in European children and adults based on urinary biomarkers: results from the "European Human Biomonitoring Initiative" HBM4EU participating studies | |
dc.type | Wissenschaftlicher Artikel | |
dc.type.dcmi | text | |
dc.type.medium | computer | |
dspace.entity.type | Publication | |
local.bibliographicCitation.journalTitle | Scientific reports | |
local.bibliographicCitation.originalDOI | 10.1038/s41598-023-48738-6 | |
local.bibliographicCitation.volume | 13 (2023), Heft 1 | |
local.collection | Aufsätze | |
local.contributor.authorId | 02193430 | |
local.contributor.authorId | 02190211 | |
local.contributor.authorId | 02160044 | |
local.identifier.catalogId | 02502617 | |
local.ingest.leader | 06483naa a2200000uu 4500 | |
local.jointTitle | DETERMINANTS OF EXPOSURE TO ACRYLAMIDE IN EUROPEAN CHILDREN AND ADULTS BASED ON URINARY BIOMARKERS RESULTS FROM THE EUROPEAN HUMAN BIOMONITORING INITIATIVE HBM4EU PARTICIPATING STUDIES | |
local.review | true | |
local.source | catalog | |
local.source.uri | http://creativecommons.org/licenses/by/4.0/deed.de | |
local.staffPublication | true | |
relation.isAuthorOfPublication | 0c3b6c3e-eff4-42d8-94e9-07a4fee4049c | |
relation.isAuthorOfPublication | 1cf84dc6-c2cf-42ad-a5a7-f540c343a6e7 | |
relation.isAuthorOfPublication | c35f06f5-f304-499f-b7b3-442daea221d8 | |
relation.isAuthorOfPublication | ecf55d24-11aa-4e19-9b41-4b6d3d1af342 | |
relation.isAuthorOfPublication | b5969380-709f-49f3-9d11-d6293091c343 | |
relation.isAuthorOfPublication | 800537d2-ed95-4cc9-973c-d54784b3cb09 | |
relation.isAuthorOfPublication.latestForDiscovery | 0c3b6c3e-eff4-42d8-94e9-07a4fee4049c |